Abnormal β-catenin immunohistochemical expression as a prognostic factor in gastric cancer: A meta-analysis

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12313-12321

  Li, Li Fu ^a   Wei, Zheng Jie ^a   Sun, Hong ^a   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Immunohistochemistry; Meta analysis; Prognosis; catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; ASSESSMENT OF HUMANS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISTANT METASTASIS; EMBASE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS; NEWCASTLE OTTAWA QUALITY ASSESSMENT SCALE.; OVERALL SURVIVAL; PROTEIN EXPRESSION; STOMACH CANCER; SYSTEMATIC REVIEW; CHEMISTRY; CHI SQUARE DISTRIBUTION; DISEASE COURSE; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK; RISK FACTOR; STOMACH NEOPLASMS; TIME;

BETA CATENIN; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84909647790     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12313     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83 [PMID: 17577615 DOI: 10.1007/s10120-007-0420-0]
3. Brenner H , Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88: 274-279 [PMID: 10640957]
4. Amedei A, Benagiano M, della Bella C, Niccolai E, D'Elios MM. Novel immunotherapeutic strategies of gastric cancer treatment. J Biomed Biotechnol 2011; 2011: 437348 [PMID: 22253528 DOI: 10.1155/2011/437348]
5. Micalizzi DS , Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010; 15: 117-134 [PMID: 20490631 DOI: 10.1007/s10911-010-9178-9]
6. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 2005; 27: 1677-1683 [PMID: 16273224]
7. Scanlon CS, Van Tubergen EA, Inglehart RC, D'Silva NJ. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 2013; 92: 114-121 [PMID: 23128109 DOI: 10.1177/0022034512467352]
8. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009; 28: 151-166 [PMID: 19153669 DOI: 10.1007/s10555-008-9179-y]
9. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999; 18: 15-30 [PMID: 10505543]
10. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 2005; 24: 5775-5789 [PMID: 16123810 DOI: 10.1038/sj.onc.1208924]
11. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM, Azuma T, Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26: 4617-4626 [PMID: 17237808 DOI: 10.1038/sj.onc.1210251]
12. Oshima H, Oshima M. The role of PGE2-associated inflammatory responses in gastric cancer development. Semin Immunopathol 2013; 35: 139-150 [PMID: 23053397 DOI: 10.1007/s00281-012-0353-5]
13. Ayed-Guerfali DB, Hassairi B, Khabir A, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance. Tumour Biol 2014; 35: 1775-1783 [PMID: 24197976 DOI: 10.1007/s13277-013-1236-7]
14. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95: 108-113 [PMID: 11241321]
15. Ramesh S, Nash J, McCulloch PG. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 1999; 81: 1392-1397 [PMID: 10604738 DOI: 10.1038/sj.bjc.6693437]
16. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605 [PMID: 20652370 DOI: 10.1007/s10654-010-9491-z]
17. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834 [PMID: 9921604]
18. Tierney JF , Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16 [PMID: 17555582 DOI: 10.1186/1745-6215-8-16]
19. Sereno M, De Castro J, Cejas P, García-Cabezas MA, Belda C, Casado E, Feliu J, Gómez C, López M, Barón MG. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer. J Gastrointest Cancer 2012; 43: 181-189 [PMID: 21360269 DOI: 10.1007/s12029-011-9267-z]
20. Hou F, Yuan W, Huang J, Qian L, Chen Z, Ge J, Wu S, Chen J, Wang J, Chen Z. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Med Oncol 2012; 29: 2691-2700 [PMID: 22189617 DOI: 10.1007/s12032-011-0127-2]
21. Sun GY, Wu JX, Wu JS, Pan YT, Jin R. Caveolin-1, E-cadherin and β-catenin in Gastric Carcinoma, Precancerous Tissues and Chronic Non-atrophic Gastritis. Chin J Cancer Res 2012; 24: 23-28 [PMID: 23359759 DOI: 10.1007/s11670-012-0023-0]
22. Liu WF, Ji SR, Sun JJ, Zhang Y, Liu ZY, Liang AB, Zeng HZ. CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer. Int J Mol Sci 2012; 13: 6399-6406 [PMID: 22754372 DOI: 10.3390/ijms13056399]
23. Ryu HS, Park do J, Kim HH, Kim WH, Lee HS. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol 2012; 43: 520-528 [PMID: 22018628 DOI: 10.1016/j.humpath.2011.07.003]
24. Retterspitz MF, Mönig SP, Schreckenberg S, Schneider PM, Hölscher AH, Dienes HP, Baldus SE. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis. Anticancer Res 2010; 30: 4635-4641 [PMID: 21115917]
25. Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology 2010; 42: 58-65 [PMID: 20025482 DOI: 10.3109/00313020903356392]
26. Czyzewska J , Guzińska-Ustymowicz K, Ustymowicz M, Pryczynicz A, Kemona A. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis. Folia Histochem Cytobiol 2010; 48: 37-45 [PMID: 20529814 DOI: 10.2478/v10042-010-0017-z]
27. Kamata I , Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Uzuki M, Fujimoto A, Morita H, Tamai S, Maehara T, Ogata K, Shimokawa R, Igarashi Y, Miki K, Ishii T. Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer. J Gastroenterol Hepatol 2009; 24: 1527-1533 [PMID: 19383080 DOI: 10.1111/j.1440-1746.2009.05810.x]
28. Zali MR, Moaven O, Asadzadeh Aghdaee H, Ghafarzadegan K, Ahmadi KJ, Farzadnia M, Arabi A, Abbaszadegan MR. Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma. J Res Med Sci 2009; 14: 239-247 [PMID: 21772890]
29. Kim MA , Lee HS, Lee HE, Kim JH, Yang HK, Kim WH. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 2009; 54: 442-451 [PMID: 19309396 DOI: 10.1111/j.1365-2559.2009.03247.x]
30. Bazas VM, Lukyanova NY, Demash DV, Galakhin KO, Myasoedov DV. Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer. Exp Oncol 2008; 30: 235-239 [PMID: 18806748]
31. Koriyama C, Akiba S, Itoh T, Sueyoshi K, Minakami Y, Corvalan A, Yonezawa S, Eizuru Y. E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance. World J Gastroenterol 2007; 13: 3925-3931 [PMID: 17663505]
32. Jung IM , Chung JK, Kim YA, Kim JE, Heo SC, Ahn YJ, Hwang KT, Kim BG, Lee KL, Kim CW, Kim WH, Chang MS. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas. J Korean Med Sci 2007; 22: 855-861 [PMID: 17982235]
33. Nabais S, Machado JC, Lopes C, Seruca R, Carneiro F, Sobrinho-Simões M. Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol 2003; 11: 1-9 [PMID: 12598910]
34. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8: 987-993 [PMID: 12439911]
35. Shun CT, Wu MS, Lin MT, Chang MC, Lin JT, Chuang SM. Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology 2001; 60: 339-345 [PMID: 11408802]
36. Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE, Mueller W. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 2001; 39: 141-149 [PMID: 11493330]
37. Joo YE, Park CS, Kim HS, Choi SK, Rew JS, Kim SJ. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer. J Korean Med Sci 2000; 15: 655-666 [PMID: 11194192]
38. Karatzas G, Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Simatos G, Papanikolaou D, Bogris S. Expression patterns of the E-cadherin-catenin cell-cell adhesion complex in gastric cancer. Hepatogastroenterology 2000; 47: 1465-1469 [PMID: 11100378]
39. Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. J Pathol 2000; 192: 433-439 [PMID: 11113859 DOI: 10.1002/1096-9896(2000)9999:9999〈::aid-path723〉3.0.co;2-v]
40. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997; 112: 46-54 [PMID: 8978342]
41. Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 2008; 468: 5-15 [PMID: 19099242 DOI: 10.1007/978-1-59745-249-6-1]
42. Huelsken J, Behrens J. The Wnt signalling pathway. J Cell Sci 2002; 115: 3977-3978 [PMID: 12356903]
43. Xing X, Tang YB, Yuan G, Wang Y, Wang J, Yang Y, Chen M. The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer 2013; 132: 2589-2596 [PMID: 23169395 DOI: 10.1002/ijc.27947]